The DOI matches its Crossref record; 131 of the 136 references it cites were found in a registry or an index.
Molecular Mechanisms of Radiation Resistance in Breast Cancer: A Systematic Review of Radiosensitization Strategies
Open accessAbstract
Breast cancer remains one of the most prevalent malignancies worldwide, and radiation therapy is a central component of its management. However, intrinsic or acquired resistance to radiation significantly compromises therapeutic efficacy. This systematic review aimed to identify and evaluate molecular mechanisms and interventions that influence radiation sensitivity in breast cancer models. A comprehensive PubMed search was conducted using the terms “breast cancer” and “radiation resistance” for studies published between 2002 and 2024. Seventy-nine eligible studies were included. The most frequently investigated mechanisms included the dysregulation of the PI3K/AKT/mTOR and MAPK signaling pathways, enhanced DNA damage repair via non-homologous end joining (NHEJ), and the overexpression of cancer stem cell markers such as CD44+/CD24−/low and ALDH1. Several studies highlighted the role of non-coding RNAs, particularly the lncRNA DUXAP8 and microRNAs such as miR-21, miR-144, miR-33a, and miR-634, in modulating radiation response. Components of the tumor microenvironment, including cancer-associated fibroblasts and immune regulators, also contributed to radiation resistance. By synthesizing current evidence, this review provides a consolidated resource to guide future mechanistic studies and therapeutic development. This review highlights promising molecular targets and emerging strategies to enhance radiosensitivity and offers a foundation for translational research aimed at improving outcomes in radiation-refractory breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 6 DNA double-strand break (DSB) repair mechanisms and their role in radiation resistance. (A) DSBs can be repaired through homologous recombination (HR) when a sister chromatid is available as a template, typically during the S and G2 phases of the cell cycle [52]. Alternatively, non-homologous end joining (NHEJ) directly ligates the broken DNA ends without a homologous template [52]. (B) Denticleless E3 ubiquitin protein ligase homolog (DTL) ubiquitinates RuvB-like AAA ATPase 1 (RUVBL1) to facilitate the formation of the RUVBL1/2–β-catenin complex, which transcriptionally upregulates genes involved in the NHEJ pathway, thereby enhancing DNA repair and promoting radiation resistance (C) Human antigen R (HuR), an RNA-binding protein often overexpressed in breast cancer, stabilizes AT-rich interaction domain 1A (ARID1A) mRNA, leading to increased ARID1A expression and enhanced DSB repair [39]. Knockdown of HuR reduces ARID1A levels, increases reactive oxygen species (ROS), and sensitizes cells to radiation by impairing DNA repair. Created in BioRender. Dickinson, N. (2025) https://BioRender.com/jhixrx1.](https://figures.cochat.ai/paper-figures/0baad7709bf14c11b2969d78ec2d1bd8/molecular-mechanisms-of-radiation-resistance-in-breast-cancer-a-systematic-figure-6.jpg)
![Figure 7 Growth factor–activated signaling pathways and their downstream targets contributing to radiation resistance in breast cancer. Summary of important signaling pathways for cancer progression and some of their downstream effects. The binding of growth factors (GF) such as EGF, PDGF, IGF, HGF, etc., to their respective ligand receptors triggers an effect throughout the PI3K/Akt/mTOR, Jak/STAT, and MAPK/ERK signaling pathways [78]. These pathways influence cancer progression and radiation resistance by influencing the regulation and activity of a variety of proteins which in turn influence factors such as apoptosis evasion, proliferation and angiogenesis [105,106,107]. Created in BioRender. Dickinson, N. (2025) https://BioRender.com/lui2zt2.](https://figures.cochat.ai/paper-figures/2e57899b3f604f2ba34649cebbaddec5/molecular-mechanisms-of-radiation-resistance-in-breast-cancer-a-systematic-figure-7.jpg)
![Figure 9 Nanoparticle-based strategies to overcome hypoxia-driven radiation resistance in breast cancer. (A) The outermost portion of a tumor is typically vascularized and well oxygenated, while the deeper portions of the tumor are less oxygenated [117]. Gold nanoparticles can increase the radiosensitivity of the cancerous cells although their effectiveness relies on the formation of ROS, so extreme hypoxia negates the change in radiosensitivity caused by the gold nanoparticles [117]. (B) Breast cancer when treated with gold nanoparticles loaded with thiolate cupferron, near-infrared treatment and ionizing radiation results in the formation of nitric oxide (NO), ROS, and reactive nitrogen species (RNS) causing cell death [118]. Created in BioRender. Dickinson, N. (2025) https://BioRender.com/e9c8tmv.](https://figures.cochat.ai/paper-figures/eaaf72a817da458c821a43a0451db1ba/molecular-mechanisms-of-radiation-resistance-in-breast-cancer-a-systematic-figure-9.jpg)






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, despite their effectiveness in amplifying radiation-induced injury, purely physical radiosensitizers often demonstrate limited ability to overcome major determinants of radioresistance, including tumor hypoxia, redox buffering capacity, and microenvironment-mediated protection [4,85,93].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Radiotherapy is a cornerstone of breast cancer treatment, but its efficacy is frequently limited by intrinsic and acquired radioresistance as well as dose-limiting toxicity to surrounding normal tissues.”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although high-Z materials effectively increase local radiation absorption, secondary electron generation, and ROS production, they do not directly address major biological determinants of radioresistance, including tumor hypoxia, antioxidant defenses, DNA repair capacity, immune suppression, and heterogeneous nanoparticle delivery [4,12,85,93].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“From a design perspective, the development of multifunctional systems reflects recognition that tumor radioresistance is multifactorial and cannot be effectively addressed through a single intervention [4,6,93].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [4]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
KEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077
KEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024) · CA: a cancer journal for clinicians · doi:10.3322/caac.21834 · Cited by 27,064
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196 · cited 2×
“Radiation resistance manifests in many ways but is often associated with an epithelial to mesenchymal transition (EMT), mutation to tumor suppressor genes, and enhanced DNA damage repair [23–25].”
Toward understanding the origin and evolution of cellular organisms
Kanehisa, M. (2019) · Protein Science · doi:10.1002/pro.3715 · Cited by 5,509
Cancer and Radiation Therapy: Current Advances and Future Directions
Baskar, R., Lee, K. A., Yeo, R., & Yeoh, K.-W. (2012) · International Journal of Medical Sciences · doi:10.7150/ijms.3635 · Cited by 2,880
KEGG: biological systems database as a model of the real world
Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y., & Ishiguro-Watanabe, M. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkae909 · Cited by 2,543
Pathological roles of MAPK signaling pathways in human diseases
Kim, E. K., & Choi, E.-J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.12.009 · Cited by 2,472
Triple-negative breast cancer molecular subtyping and treatment progress
Yin, L., Duan, J.-J., Bian, X.-W., & Yu, S.-C. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01296-5 · Cited by 2,452
Breast Cancer Statistics, 2022
Giaquinto, A. N., Sung, H., Miller, K. D., Kramer, J. L., Newman, L. A., Minihan, A., Jemal, A., & Siegel, R. L. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21754 · Cited by 2,286
Cited by
Dickinson, N., Murray, A., Davis, M., Marshall-Bergeron, K., Dougherty, J., Al-Khayyat, W., Narendrula, R., Lavoie, M., Mageau, E., Derbowka, R., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199611 · Cited by 3
Self-citationLunca, S., Morarasu, S., & Dimofte, G. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146522 · Cited by 2
“Radioresistance in breast cancer is a multifactorial process involving tumor cell-intrinsic mechanisms, including enhanced DNA damage repair capacity, dysregulated cell cycle checkpoints, and resistance to apoptosis, as well as extrinsic factors related to the tumor microenvironment [4].”
InfluentialFaryal, B. (2025) · Cancer Reports · doi:10.1002/cnr2.70389 · Cited by 6
Molecular Pharmacology at the Crossroads of Precision Medicine
Nicolae, A. C., Dumitrescu, I.-B., & Drăgoi, C. M. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb48010039 · Cited by 2
Thảo, Đ. T., Quyền, Đ. V., Song, L. H., & Trung, N. T. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1663823 · Cited by 1
Metadata
- Authors
- Mageau, E., Derbowka, R., Dickinson, N., Lefort, N., Kovala, A. T., Boreham, D. R., Tai, T. C., Thome, C., & Tharmalingam, S.
- Affiliations
- Laurentian University (CA)
- NOSM University (CA)
- Health Sciences North (CA)
- Corresponding author
- Tharmalingam, Sujeenthar
- ORCID
- Venue
- Current Issues in Molecular Biology
- Publisher
- MDPI AG
- Published
- 2025-07-24
- Volume
- 47
- Issue
- 8
- Pages
- 589
- ISSN
- 1467-3037 (ISSN-L)
- 1467-3045
- PMC
- PMC12384436
- OpenAlex
- W4412628978
- Cited by
- 12
- References
- 136
- Citations by year
- 2026: 8 · 2025: 4
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Current Issues in Molecular Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- NSERC Discovery Grant
- Northern Cancer Foundation
- Northern Ontario School of Medicine University Faculty Association Research Development Award
- Canada Graduate Scholarships—Master’s program
- Ontario Graduate Scholarship
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- breast cancer, radioresistance (biology), radiosensitization, PI3K/AKT/mTOR pathway, MAPK signaling, DNA repair, non-homologous end joining, cancer stem cells, CD44, ALDH1, non-coding RNA, DUXAP8, microRNA, miR-21, tumor microenvironment, cancer-associated fibroblasts, immune regulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Molecular Mechanisms of Radiation Resistance in Breast Cancer: A Systematic Review of Radiosensitization Strategies. https://app.cochat.ai/papers/10.3390/cimb47080589
- The paper
- Mageau, E., Derbowka, R., Dickinson, N., Lefort, N., Kovala, A. T., Boreham, D. R., Tai, T. C., Thome, C., & Tharmalingam, S. (2025). Molecular Mechanisms of Radiation Resistance in Breast Cancer: A Systematic Review of Radiosensitization Strategies. Current Issues in Molecular Biology. https://doi.org/10.3390/cimb47080589
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.